←Back to Expert Scholars
Translational Medicine / 转化医学Esophageal Squamous Cell Carcinoma Asia
Lin Shen
MD, PhD
🏢Peking University Cancer Hospital🌐China
Director, Department of GI Oncology
78
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lin Shen leads the GI oncology department at Peking University Cancer Hospital and has been pivotal in Chinese immunotherapy trials for ESCC. Her research has contributed to regulatory approvals of multiple anti-PD-1 agents for esophageal cancer in China. She is one of the most influential GI oncologists in Asia-Pacific.
Share:
🧪Research Fields 研究领域
Esophageal squamous cell carcinoma
Gastric cancer
Immunotherapy China
Anti-PD-1 therapy
GI oncology leadership
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lin Shen 的研究动态
Follow Lin Shen's research updates
留下邮箱，当我们发布与 Lin Shen（Peking University Cancer Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment